MirZyme has several patented pipelines of product offerings that address the unmet medical needs of patients with preeclampsia and FGR. Uniquely, MirZyme will be the first to provide therapeutics with a companion diagnostic test for preeclampsia. 

​

​

​

The clinical developement programme of these products will compliment each other and run in parallel. The products follow independent routes to market and timelines, thus de-risking the business model. The table below shows MirZyme’s product list in order of current development status and time to market.